These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24718793)

  • 41. Plant TOR signaling components.
    John F; Roffler S; Wicker T; Ringli C
    Plant Signal Behav; 2011 Nov; 6(11):1700-5. PubMed ID: 22057328
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
    Han S; Khuri FR; Roman J
    Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TORC1 kinase and the S-phase cyclin Clb5 collaborate to promote mitotic spindle assembly and DNA replication in S. cerevisiae.
    Tran LT; Wang'ondu RW; Weng JB; Wanjiku GW; Fong CM; Kile AC; Koepp DM; Hood-DeGrenier JK
    Curr Genet; 2010 Dec; 56(6):479-93. PubMed ID: 20697716
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recent developments in targeting the mammalian target of rapamycin (mTOR) kinase pathway.
    Smolewski P
    Anticancer Drugs; 2006 Jun; 17(5):487-94. PubMed ID: 16702804
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Target of rapamycin (TOR) controls vitellogenesis via activation of the S6 kinase in the fat body of the tick, Haemaphysalis longicornis.
    Umemiya-Shirafuji R; Boldbaatar D; Liao M; Battur B; Rahman MM; Kuboki T; Galay RL; Tanaka T; Fujisaki K
    Int J Parasitol; 2012 Oct; 42(11):991-8. PubMed ID: 22985802
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rapamycin resistance is linked to defective regulation of Skp2.
    Totary-Jain H; Sanoudou D; Dautriche CN; Schneller H; Zambrana L; Marks AR
    Cancer Res; 2012 Apr; 72(7):1836-43. PubMed ID: 22311674
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mdm20 Modulates Actin Remodeling through the mTORC2 Pathway via Its Effect on Rictor Expression.
    Yasuda K; Takahashi M; Mori N
    PLoS One; 2015; 10(11):e0142943. PubMed ID: 26600389
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pemetrexed indirectly activates the metabolic kinase AMPK in human carcinomas.
    Rothbart SB; Racanelli AC; Moran RG
    Cancer Res; 2010 Dec; 70(24):10299-309. PubMed ID: 21159649
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mirk/dyrk1B kinase is upregulated following inhibition of mTOR.
    Deng X; Hu J; Ewton DZ; Friedman E
    Carcinogenesis; 2014 Sep; 35(9):1968-76. PubMed ID: 24590896
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rapamycin and glucose-target of rapamycin (TOR) protein signaling in plants.
    Xiong Y; Sheen J
    J Biol Chem; 2012 Jan; 287(4):2836-42. PubMed ID: 22134914
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of the mTOR/p70S6K pathway is not involved in the insulin-sensitizing effect of AMPK on cardiac glucose uptake.
    Ginion A; Auquier J; Benton CR; Mouton C; Vanoverschelde JL; Hue L; Horman S; Beauloye C; Bertrand L
    Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H469-77. PubMed ID: 21602475
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HCG-mediated activation of mTORC1 signaling plays a crucial role in steroidogenesis in human granulosa lutein cells.
    Moravek MB; Shang M; Menon B; Menon K
    Endocrine; 2016 Oct; 54(1):217-224. PubMed ID: 27503318
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activation of mammalian target of rapamycin signaling in spatial learning.
    Qi S; Mizuno M; Yonezawa K; Nawa H; Takei N
    Neurosci Res; 2010 Oct; 68(2):88-93. PubMed ID: 20599569
    [TBL] [Abstract][Full Text] [Related]  

  • 54. mTOR complex 2 regulates proper turnover of insulin receptor substrate-1 via the ubiquitin ligase subunit Fbw8.
    Kim SJ; DeStefano MA; Oh WJ; Wu CC; Vega-Cotto NM; Finlan M; Liu D; Su B; Jacinto E
    Mol Cell; 2012 Dec; 48(6):875-87. PubMed ID: 23142081
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Architecture and activation of phosphatidylinositol 3-kinase related kinases.
    Imseng S; Aylett CH; Maier T
    Curr Opin Struct Biol; 2018 Apr; 49():177-189. PubMed ID: 29625383
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts.
    Cao X; Kambe F; Moeller LC; Refetoff S; Seo H
    Mol Endocrinol; 2005 Jan; 19(1):102-12. PubMed ID: 15388791
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An overview of rapamycin: from discovery to future perspectives.
    Yoo YJ; Kim H; Park SR; Yoon YJ
    J Ind Microbiol Biotechnol; 2017 May; 44(4-5):537-553. PubMed ID: 27613310
    [TBL] [Abstract][Full Text] [Related]  

  • 58. mTORC1 inhibition induces pain via IRS-1-dependent feedback activation of ERK.
    Melemedjian OK; Khoutorsky A; Sorge RE; Yan J; Asiedu MN; Valdez A; Ghosh S; Dussor G; Mogil JS; Sonenberg N; Price TJ
    Pain; 2013 Jul; 154(7):1080-91. PubMed ID: 23607966
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [mTORC1 and sirolimus: a link with fertility].
    Tartarin P; Froment P
    Med Sci (Paris); 2013 Feb; 29(2):200-5. PubMed ID: 23452608
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Luteinizing hormone stimulates mammalian target of rapamycin signaling in bovine luteal cells via pathways independent of AKT and mitogen-activated protein kinase: modulation of glycogen synthase kinase 3 and AMP-activated protein kinase.
    Hou X; Arvisais EW; Davis JS
    Endocrinology; 2010 Jun; 151(6):2846-57. PubMed ID: 20351317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.